ArticleJournal of orthopaedic surgery and research2025
Management of Dupuytren disease of the little finger.
Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe surgical management of Dupuytren disease (DD) is associated with a high rate of complications. Recurrences are relatively common and may result in permanent disability, particularly when the little finger (LF) is involved. This study aims to provide both objective and subjective information, along with professionals' experiences.
methodsA questionnaire survey, comprising both open and closed questions, was distributed to hand surgeons, physiotherapists, and occupational therapists engaged in the management of DD across five continents. The involvement and role of the LF in DD were extensively highlighted and emphasised. Only consistent answers were included. A total of 588 questionnaires were completed.
results50% (n = 294) of the answers were from hand surgeons, 24% (n = 141) from physiotherapists and 26% (n = 153) from occupational therapists. 76.5% (n = 153) of the healthcare professionals (HCP) agreed that: "The LF does not necessarily benefit from good results. Rehabilitation, just like surgery, can be delicate and difficult.". Different agreements were found between surgeons and occupational therapists (p = 0.007) and among surgeons, depending on their surgical experience (p = 0.008). No significant differences were seen between surgeons and physiotherapists.
conclusionsThe LF in Dupuytren's disease requires special attention during surgery and rehabilitation. All healthcare professionals (HCPs) should invest in patient education to ensure early referral and optimal adherence to treatments. Further high-quality research is warranted to achieve a definitive consensus on optimal treatment and rehabilitation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.